Tectonic Therapeutic (TECX) Change in Account Payables (2017 - 2026)
Tectonic Therapeutic's (TECX) quarterly Change in Account Payables came in at $1.4 million in Q1 2026, down 12.69% year-on-year from $1.6 million in Q1 2025, and up 503.21% on a QoQ basis from -$343000.0 in Q4 2025.
Tectonic Therapeutic (TECX) Change in Account Payables (2017 - 2026) Analysis & Trends
Tectonic Therapeutic (TECX) has 10 years of Change in Account Payables data on file, last reported at $1.4 million in Q1 2026.
- On a quarterly basis, Change in Account Payables fell 12.69% year-over-year to $1.4 million in Q1 2026; TTM through Mar 2026 was -$85000.0, a 93.69% increase from a year earlier, with the FY2025 full-year figure at $116000.0, up 108.16% from the prior year.
- Change in Account Payables for Q1 2026 stood at $1.4 million, up from -$343000.0 in the prior quarter.
- Over the last five years, Change in Account Payables for TECX reached as high as $2.3 million in Q3 2023 and fell as low as -$4.2 million in Q4 2023.
- Historically, Change in Account Payables has averaged -$187588.2 across 5 years, with a median of $137000.0 in 2025.
- Across the five-year window, Change in Account Payables surged 2219.23% in 2022 and slumped 1567.44% in 2025, its largest moves.
- Year by year, Change in Account Payables stood at -$1.4 million in 2022, then tumbled by 192.59% to -$4.2 million in 2023, then soared by 65.65% to -$1.4 million in 2024, then soared by 76.13% to -$343000.0 in 2025, then soared by 503.21% to $1.4 million in 2026.
- Per Business Quant data, the three most recent Change in Account Payables figures were $1.4 million in Q1 2026, -$343000.0 in Q4 2025, and -$1.3 million in Q3 2025.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Change in Account Payables (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 68,785.72 Bn | 68,785.72 Bn | - | - |
| 2 | Nanobiotix | 1,895.57 Bn | 1,895.51 Bn | - | - |
| 3 | BeOne Medicines | 471.35 Bn | 466.56 Bn | 1.35 Bn | -42.19 Mn |
| 4 | NuCana | 279.75 Bn | 279.75 Bn | - | -1.52 Mn |
| 5 | Vertex Pharmaceuticals | 120.24 Bn | 113.00 Bn | 2.59 Bn | 35.60 Mn |
| 6 | Regeneron Pharmaceuticals | 67.80 Bn | 59.04 Bn | 3.31 Bn | - |
| 7 | Belite Bio | 62.51 Bn | 62.51 Bn | - | - |
| 8 | Argenx Se | 57.38 Bn | 57.38 Bn | 1.41 Bn | - |
| 9 | Revolution Medicines | 37.78 Bn | 37.78 Bn | - | 16.86 Mn |
| 10 | Tectonic Therapeutic | 595.23 Mn | 595.23 Mn | - | 1.38 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 1.38 Mn |
| Mar 31, 2026 | 1.38 Mn |
| Dec 31, 2025 | -343,000.00 |
| Dec 31, 2025 | -343,000.00 |
| Sep 30, 2025 | -1.26 Mn |
| Sep 30, 2025 | -1.26 Mn |
| Jun 30, 2025 | 137,000.00 |
| Jun 30, 2025 | 137,000.00 |
| Mar 31, 2025 | 1.58 Mn |
| Mar 31, 2025 | 1.58 Mn |
| Dec 31, 2024 | -1.44 Mn |
| Dec 31, 2024 | -1.44 Mn |
| Sep 30, 2024 | 86,000.00 |
| Sep 30, 2024 | 86,000.00 |
| Jun 30, 2024 | -1.58 Mn |
| Jun 30, 2024 | -1.58 Mn |
| Mar 31, 2024 | 1.51 Mn |
| Mar 31, 2024 | 1.51 Mn |
| Dec 31, 2023 | -4.18 Mn |
| Dec 31, 2023 | -4.18 Mn |